There were several news stories recently that reported that Pfizer had abandoned its efforts to have its Lipitor brand of atorvastatin made available over the counter (OTC), without a prescription. I was never a big fan of OTC statins, but I was struck by the reason that Pfizer put out: The study did not meet its primary […]
via Medicine Joint Channels
No hay comentarios:
Publicar un comentario